ID   VAB5
AC   CVCL_S600
DR   Wikidata; Q54992649
RX   Patent=US6660276;
RX   PubMed=7681084;
CC   HLA typing: A*02,25; B*60,62; C*03 (PubMed=7681084).
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 7
//
RX   Patent=US6660276;
RA   Slingluff, Craig L. Jr.
RA   Engelhard, Victor H.
RA   Hunt, Donald Frederick
RA   Shabanowitz, Jeffrey
RA   Cox, Andrea L.
RT   "Peptides recognized by melanoma-specific cytotoxic lymphocytes, and
RT   uses therefor.";
RL   Patent number US6660276, 09-Dec-2003.
//
RX   PubMed=7681084; DOI=10.4049/jimmunol.150.7.2955;
RA   Slingluff, Craig L. Jr.
RA   Cox, Andrea L.
RA   Henderson, Ralph A.
RA   Hunt, Donald Frederick
RA   Engelhard, Victor H.
RT   "Recognition of human melanoma cells by HLA-A2.1-restricted cytotoxic
RT   T lymphocytes is mediated by at least six shared peptide epitopes.";
RL   J. Immunol. 150:2955-2963(1993).
//